B58.89 Toxoplasmosis with other organ involvement

Name of the Condition

• Toxoplasmosis with other organ involvement

Summary

Toxoplasmosis with other organ involvement is a manifestation of infection with the protozoan parasite Toxoplasma gondii that affects organs beyond the brain, eyes, or liver. It may present as an acute or chronic condition, with clinical severity varying based on the host's immune status and the specific organ(s) involved. While often asymptomatic in immunocompetent individuals, it can cause significant dysfunction in immunocompromised patients or those with congenital infection.

Causes

The condition is caused by Toxoplasma gondii, a parasite that can infect various tissues through congenital transmission or reactivation of latent infection. Transmission occurs via ingestion of contaminated food or water, contact with cat feces containing oocysts, or consumption of undercooked meat harboring tissue cysts. In affected organs, the parasite can invade tissues, triggering inflammatory responses that may lead to organ-specific complications.

Risk Factors

• Immunocompromised states, such as HIV/AIDS, organ transplantation, or chemotherapy.
• Pregnancy, especially if the mother acquires the infection during gestation.
• Consumption of undercooked or raw meat, particularly pork, lamb, or venison.
• Exposure to cat feces, including cleaning litter boxes or gardening in soil potentially contaminated with oocysts.
• Advanced age or systemic co-morbidities that impair immune function.

Symptoms

Symptoms depend on the organ(s) involved and may include fever, fatigue, organ-specific pain (e.g., abdominal, chest, or muscle pain), and signs of organ dysfunction (e.g., jaundice, shortness of breath, or neurological deficits). Immunocompromised patients may experience more severe or atypical presentations.

Diagnosis

Diagnosis involves clinical evaluation, imaging (e.g., CT, MRI, or ultrasound) to identify organ involvement, and laboratory tests (e.g., serology, PCR, or tissue biopsy) to detect Toxoplasma gondii or its antigens. Histopathological examination of affected tissue may reveal characteristic inflammatory changes or parasite cysts.

Treatment Options

Treatment typically includes antiparasitic medications (e.g., pyrimethamine, sulfadiazine, or clindamycin) and supportive care. Duration and regimen depend on the severity of infection, organ involvement, and patient immune status. Immunocompromised patients may require prolonged therapy to prevent reactivation.

Prognosis and Follow-Up

Prognosis varies by organ involvement and immune status. Immunocompetent individuals often recover fully with treatment, while immunocompromised patients may experience chronic or recurrent disease. Follow-up includes monitoring for treatment response, organ function, and potential complications, with adjustments to therapy as needed.

Complications

Complications may include organ damage (e.g., fibrosis, necrosis), secondary infections, or systemic spread. In severe cases, organ failure or death can occur, particularly in immunocompromised patients or those with untreated congenital infection.

Lifestyle & Prevention

• Avoid undercooked meat and unpasteurized dairy products.
• Practice good hand hygiene after handling raw meat or soil.
• Avoid contact with cat feces (e.g., delegate litter box cleaning to others, wear gloves when gardening).
• Immunocompromised individuals should consult healthcare providers for prophylactic measures.

When to Seek Professional Help

Seek care if symptoms of organ dysfunction (e.g., jaundice, chest pain, or neurological changes) develop, especially in immunocompromised patients or pregnant individuals. Prompt evaluation is critical for early diagnosis and treatment.

Tips for Medical Coders

Document the specific organ(s) involved and any associated complications to support code assignment. Ensure clinical documentation aligns with the ICD-10-CM guidelines for B58.89, emphasizing organ-specific involvement beyond the brain, eyes, or liver. Include details on immune status, transmission route, or treatment response when available to clarify the clinical context.